**Core Concept**
Thalidomide is a unique immunomodulatory drug with anti-inflammatory and anti-angiogenic properties. It was originally introduced as a sedative but was withdrawn due to its teratogenic effects. However, it has found a new role in the treatment of certain diseases.

**Why the Correct Answer is Right**
Thalidomide is the drug of choice for **Erythema Nodosum Leprosum (ENL)**, a type of skin reaction that occurs in some patients with leprosy. The exact mechanism of thalidomide's action in ENL is not fully understood, but it is thought to involve the inhibition of tumor necrosis factor-alpha (TNF-alpha) and other pro-inflammatory cytokines. Thalidomide also has anti-angiogenic properties, which may help to reduce the inflammation and skin lesions associated with ENL.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because thalidomide is not typically used to treat multiple myeloma, although it may be used in combination with other medications for this condition.
* **Option B:** This option is incorrect because thalidomide is not used to treat Crohn's disease, although it has been studied as a potential treatment for this condition.
* **Option C:** This option is incorrect because thalidomide is not used to treat rheumatoid arthritis, although it has been studied as a potential treatment for this condition.

**Clinical Pearl / High-Yield Fact**
Thalidomide is a high-risk medication due to its teratogenic effects, and it should only be prescribed to patients who are taking adequate birth control measures.

**Correct Answer: C. Erythema Nodosum Leprosum (ENL)**